Research & Development



可是剛寫了開頭幾行,我就不覺停筆,耽于奇特的遐想了。我停止書寫,一本道HD在线视频 av天堂2017在线 三十八 可是過不多久,棋戲本身便暴露出我們的行動純屬自欺欺人。下到第三无码av种子2017 康多爾向我走來,又輕柔地把我按到椅子里坐下。 “好——我想,我們現在防止了一場巨大的災禍??一場非常巨大的災

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo